BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11600580)

  • 1. Transforming events in thyroid tumorigenesis and their association with follicular lesions.
    Heaney AP; Nelson V; Fernando M; Horwitz G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5025-32. PubMed ID: 11600580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
    Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer.
    Kim DS; Franklyn JA; Stratford AL; Boelaert K; Watkinson JC; Eggo MC; McCabe CJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1119-28. PubMed ID: 16394085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
    Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway.
    Kim DS; Franklyn JA; Boelaert K; Eggo MC; Watkinson JC; McCabe CJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4603-11. PubMed ID: 16926250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells.
    Kim D; Pemberton H; Stratford AL; Buelaert K; Watkinson JC; Lopes V; Franklyn JA; McCabe CJ
    Oncogene; 2005 Jul; 24(30):4861-6. PubMed ID: 15897900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
    van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
    Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
    Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer.
    Sáez C; Martínez-Brocca MA; Castilla C; Soto A; Navarro E; Tortolero M; Pintor-Toro JA; Japón MA
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1404-9. PubMed ID: 16418208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
    Kim CS; Ying H; Willingham MC; Cheng SY
    Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
    Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.
    Horwitz GA; Miklovsky I; Heaney AP; Ren SG; Melmed S
    Mol Endocrinol; 2003 Apr; 17(4):600-9. PubMed ID: 12554778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy.
    Nelson KK; Gattuso P; Xu X; Prinz RA
    Surgery; 2010 Oct; 148(4):654-60; discussion 660. PubMed ID: 20797751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.
    Ferraro A; Schepis F; Leone V; Federico A; Borbone E; Pallante P; Berlingieri MT; Chiappetta G; Monaco M; Palmieri D; Chiariotti L; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2834-43. PubMed ID: 23666966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin: a differentiation marker in thyroid malignancies.
    Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
    Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.